MRSA & Salmonella in Animal & Human

• In poultry, Salmonella colonizes the gut and reproductive tract, contaminating eggs, meat, and litter. It often spreads undetected through asymptomatic carriers.

• In humans, it causes severe gastrointestinal infections and, in the case of S. typhi, typhoid fever causes a life-threatening illness in many parts of the world.

Salmonella (including S. typhi)

Methicillin Resistant S. aureus (MRSA)

• In poultry, MRSA causes joint infections (arthritis), skin abscesses, dermatitis, and even sepsis, leading to reduced growth, higher mortality, and economic losses.

• It can transfer to humans via handling or consumption, where it causes wound infections, pneumonia, or bloodstream infections—often hard to treat due to resistance.

GREEN ANTIBIOTICS INNOVATION

Leadership, Expertise and Proof of Concept

At Avix Pharmaceuticals Limited, we are at the forefront of developing natural, plant-based alternatives to antibiotics for animal agriculture. Led by Dr Md Arif Sheikh and Dr David Brown (pioneer of the Antibiotic Resistance Breaker theory), our team has tested 41 proprietary Green Antibiotics™ cocktails to combat antimicrobial resistance (AMR) in livestock pathogens.

In the study shown above, two of the most dangerous and drug-resistant bacteria, Methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Salmonella typhi, were exposed to both traditional antibiotics and Green Antibiotics™ cocktails.

• The chemical antibiotic alone showed virtually no or little effect.

• In contrast, our plant-based combinations produced clear zones of bacterial inhibition, with the triple cocktail (A© + B© + C©) achieving the strongest results, up to 20 mm in Salmonella typhi and 15 mm in MRSA.

These findings were reproducible and robust, confirming that Green Antibiotics™ can not only match but exceed the efficacy of synthetic drugs, with none of the harmful residues or side effects

The Green Antibiotics Advantage

• No residues in meat, eggs, or environment.

• No withdrawal period, safe for daily use.

• No side effects for animals or humans.

• 7 blockbuster-ready formulations, each tested and ready to launch within 6 months.

Green Antibiotics™ is not just a concept—it’s a scientifically validated, export-ready innovation that positions Bangladesh as a global leader in antibiotic-free animal health.

OUR STRATEGY

Benefits of Green Antibiotics

Safe and Natural

Green antibiotics are derived from plants, ensuring a natural and safe alternative to synthetic antibiotics.

Effective Against AMR

Our green antibiotics target antibiotic-resistant bacteria at their source, reducing the spread of AMR and preserving the effectiveness of existing antibiotics.

Economic Viability

By offering a sustainable antimicrobial option, green antibiotics support the economic viability of the aquaculture and poultry sectors, ensuring these industries can thrive without compromising public health.

Antibiotic Use in Animal Agriculture

Global Overview

• Total Usage: Over 70% of antibiotics sold globally are used in food production animals.

• Growth Projections: Use is expected to increase by 67% from 2010 to 2030, especially in middle-income countries.

Regional Insights

• United States: 80% of antibiotics are used in livestock.

• European Union: Banned antibiotics as growth promoters since 2006.

• China: Largest consumer, using 50% of global veterinary antibiotics.

• India: Rapid increase due to expanding animal agriculture industries.

Billion Dollar Market

Increased awareness of antimicrobial resistance (AMR) and stricter regulations on antibiotic use in agriculture drive demand for sustainable alternatives. Green antibiotics, derived from natural plant compounds, address both health and environmental concerns.

Market Drivers:

• Rising AMR Awareness: AMR dangers fuels the need of new innovation

• Regulatory Changes: Stricter regulations on livestock antibiotic use

• Consumer Demand: Preference for antibiotic free food production

• Economic Benefits: Green antibiotics has the opportunity to enter $200B aquaculture and $350B poultry sectors, maintaining productivity while complying with regulations.